On 1/22/25, EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) stock enjoyed a major increase of 14.3%, closing at $8.72. This advance was accompanied by normal trading volume. Relative to the market the stock has been extremely weak over the last nine months but has risen 12.5% during the last week.
Current PriceTarget Research Rating
EyePoint Pharmaceuticals has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. EyePoint Pharmaceuticals has a slightly positive Appreciation Score of 60 but a very low Power Rating of 7, with the Negative Value Trend Rating the result.
Rating Review
In light of this very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment